SOS1 inhibition in combination with HER2 inhibition in models of HER2driven cancer

被引：0
作者：
Schenk, Robyn L.
Kostyrko, Kaja
Popow, Johannes
Gewinner, Christina
Baum, Anke
Albrecht, Christoph
Hinkel, Melanie
Jacob, Robin
Madensky, Tom
Ruzicka, Regina
Strauss, Eva
Lyu, Hengyu
Lopez, Anastasia M.
Feng, Ningping
Vellano, Christopher P.
Marszalek, Joseph R.
Heffernan, Timothy P.
Pearson, Mark
Hofmann, Marco H.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6506
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR and HER2 inhibition in pancreatic cancer
    Naomi Walsh
    Susan Kennedy
    AnneMarie Larkin
    Brendan Corkery
    Lorraine O’Driscoll
    Martin Clynes
    John Crown
    Norma O’Donovan
    Investigational New Drugs, 2013, 31 : 558 - 566
  • [2] EGFR and HER2 inhibition in pancreatic cancer
    Walsh, Naomi
    Kennedy, Susan
    Larkin, AnneMarie
    Corkery, Brendan
    O'Driscoll, Lorraine
    Clynes, Martin
    Crown, John
    O'Donovan, Norma
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 558 - 566
  • [3] Dual HER2 inhibition
    Landman, Allison
    LANCET ONCOLOGY, 2023, 24 (07) : 724 - 724
  • [4] Dual inhibition of HER2 in breast cancer treatment
    Gnant, Michael
    Steger, Guenther G.
    LANCET, 2012, 379 (9816) : 596 - 598
  • [5] Inhibition of mutationally activated HER2
    Collins, Stephen J.
    Guo, Jiaye
    Rizzo, Robert C.
    Miller, W. Todd
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (01) : 87 - 102
  • [6] Modeling HER2 Inhibition in Breast Cancer Cells
    Fink, Marc Y.
    Zhou, Danni
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 614A - 614A
  • [7] Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer
    Marin, Arnaldo
    Al Mamun, Abdullah
    Patel, Hima
    Akamatsu, Hiroaki
    Ye, Dan
    Sudhan, Dhivya R.
    Eli, Lisa
    Marcelain, Katherine
    Brown, Benjamin P.
    Meiler, Jens
    Arteaga, Carlos L.
    Hanker, Ariella B.
    CANCER RESEARCH, 2023, 83 (18) : 3145 - 3158
  • [8] Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance
    Emde, Anna
    Mahlknecht, Georg
    Maslak, Kerstin
    Ribba, Benjamin
    Sela, Michael
    Possinger, Kurt
    Yarden, Yosef
    TRANSLATIONAL ONCOLOGY, 2011, 4 (05): : 293 - 300
  • [9] Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer
    Kanthala, Shanthi
    Banappagari, Sashikanth
    Gokhale, Ameya
    Liu, Yong-Yu
    Xin, Gu
    Zhao, Yunfeng
    Jois, Seetharama
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 702 - 714
  • [10] Dual HER2 inhibition and paclitaxel in metastatic breast cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2015, 16 (02) : E57 - E57
12345